NASDAQ: ACRS       Aclaris Therapts
Last Price Today's Change   Day's Range   Trading Volume
1.535   -0.115 (6.97%)  1.53 - 1.67  294,958


Avg Volume (4 weeks):1,031,800
4 Weeks Range:1.26 - 2.22
4 Weeks Price Volatility (%):
52 Weeks Range:0.70 - 2.49
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which operates in United States. It focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company holds a drug candidate, A-101 Topical Solution which is a proprietary high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis (SK) a common non-malignant skin tumor. Its pipeline of drug candidates includes A-101 as a Topical Solution for treatment of SK, common warts; A-102 as a gel dosage form for treatment of SK and warts and A-201 and A-301 as an oral and topical formulation for treatment of autoimmune dermatologic respectively.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2088  3737  247  2992 

Top 10 Active Counters
 GNUS 3.59+1.28 
 NIO 9.26+1.35 
 LK 1.38-1.62 
 SOLO 3.22+0.89 
 WKHS 21.243+2.063 
 AAL 12.545-0.265 
 AVP 5.60-0.05 
 SQQQ 7.05-0.24 
 PCG 9.60+0.57 
 GE 6.835+0.095 
Partners & Brokers